Erythromycin

BreastfeedingGeriatric
  • TRADE NAMES: E-Mycin; EES; Eramycin; Ery-Ped; Ery-Tab; Eryc (Warner Chilcott); Erypar; Erythrocin; Eryzole; Ilosone; Ilotycin; PCE (AbbVie); Pediazole; Robimycin; Wintrocin; Wyamicin S
  • INDICATIONS: Various infections caused by susceptible organisms
  • CLASS: Antibiotic; macrolide, CYP3A4 inhibitor
  • HALF-LIFE: 1.4–2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Afatinib, Alfentanil, Aminophylline, Amisulpride, Amoxicillin, Ampicillin, Anticonvulsants, Arsenic, Astemizole, Atorvastatin, Avanafil, Benzodiazepines, Bosentan, Bromocriptine, Buprenorphine, Bupropion, Carbamazepine, Cilostazol, Ciprofloxacin, Cisapride, Clindamycin, Clindamycin/Tretinoin, Clopidogrel, Clozapine, Colchicine, Cyclosporine, CYP3A inhibitors, Darifenacin, Dasatinib, Digoxin, Dihydroergotamine, Diltiazem, Disopyramide, Docetaxel, Doxercalciferol, Dronedarone, Enoxacin, Eplerenone, Ergotamine, Estradiol, Eszopiclone, Everolimus, Flibanserin, Fluconazole, Fluoxetine, Fluvastatin, Gatifloxacin, HMG-CoA reductase inhibitors, Imatinib, Indacaterol, Itraconazole, Ketoconazole, Levodopa, Lomefloxacin, Lorazepam, Lovastatin, Methadone, Methylergonovine, Methylprednisolone, Methysergide, Midazolam, Mifepristone, Mizolastine, Moxifloxacin, Naldemedine, Naloxegol, Neratinib, Nintedanib, Nitrazepam, Norfloxacin, Ofloxacin, Olaparib, Oxtriphylline, Paroxetine Hydrochloride, Pentamidine, Pimecrolimus, Pimozide, Pitavastatin, Pravastatin, Quetiapine, Quinolones, Ranolazine, Repaglinide, Rilpivirine, Rivaroxaban, Roflumilast, Rosuvastatin, Rupatadine, Sertraline, Sildenafil, Silodosin, Simeprevir, Simvastatin, Sparfloxacin, Sulpiride, Tacrolimus, Tadalafil, Tamsulosin, Terfenadine, Tezacaftor/Ivacaftor, Tramadol, Triamcinolone, Triazolam, Troleandomycin, Vardenafil, Venetoclax, Verapamil, Vilazodone, Vinblastine, Warfarin, Zafirlukast, Zaleplon, Zolpidem, Zuclopenthixol

PREGNANCY CATEGORY: B

Our database has 66 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
OTHER.


Page last updated 07/10/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top